Allspring Global Investments Holdings, LLC Nurix Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 89,920 shares of NRIX stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,920
Previous 140,273
35.9%
Holding current value
$1.35 Million
Previous $3.15 Million
46.21%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding NRIX
# of Institutions
185Shares Held
70.6MCall Options Held
318KPut Options Held
42.4K-
Black Rock Inc. New York, NY6.82MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$65.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$62.9 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$58.2 Million0.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.59MShares$53.8 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $707M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...